In-vitro effect of edta-tris-lysozyme solutions on selected pathogenic bacteria.
The in-vitro effect of EDTA-Tris-lysozyme solution on 16 pathogenic bacteria of medical or veterinary importance was determined. Marked decreases in bacterial count occurred with Pseudomonas aeruginosa, Escherichia coli, Moraxella osloensis and Campylobacter fetus, and smaller decreses with Salmonella typhimurium, Shigella boydii, Aeromonas hydrophila, proteus mirabilis, Listeria monocytogenes and Erysipelothrix insidiosa. The test solution had no effect on Klebsiella ozaenae, Brucella canis, Cornynebacterium pyogenes, Coryne, renale, Streptococcus equi and staphylococcus aureus.
D000333:Aeromonas / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002168:Campylobacter fetus / Q000187:drug effects; D002452:Cell Count; D004492:Edetic Acid / Q000494:pharmacology*; D004888:Erysipelothrix / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D008089:Listeria monocytogenes / Q000187:drug effects; D009016:Moraxella / Q000187:drug effects; D009113:Muramidase / Q000494:pharmacology*; D011513:Proteus mirabilis / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012486:Salmonella typhimurium / Q000187:drug effects; D012761:Shigella boydii / Q000187:drug effects; D012996:Solutions; D014325:Tromethamine / Q000494:pharmacology*
D012996:Solutions; D014325:Tromethamine; D004492:Edetic Acid; D009113:Muramidase